Table: Solasia Pharma -2024 parent results
Feb 12 (Reuters)-
Solasia Pharma K. K.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Dec 31, 2024 Dec 31, 2023 Dec 31, 2025 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 316 mln 617 mln
(-48.7 pct) (-43.5 pct)
Operating loss 840 mln loss 688 mln
Recurring loss 869 mln loss 678 mln
Net loss 868 mln loss 679 mln
EPS loss 4.37 yen loss 4.04 yen
EPS Diluted loss 4.37 yen loss 4.04 yen
Ann Div NIL NIL NIL
-Q2 Div NIL NIL NIL
-Q4 Div NIL NIL NIL
NOTE - Solasia Pharma K. K..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4597.T